Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Future Medicinal Chemistry|March 24, 2011
Recent advances in the biology and medicinal chemistry of TRPA1Jason C Rech, William A Eckert, Michael P Maher, et al.
ACS Chemical Biology|August 7, 2025
CRISPR RiPCA for Investigating eIF4E-m7GpppX Capped mRNA InteractionsGabriela Vega-Hernández, Jesse Duque, Brandon J C Klein, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
CRISPR RiPCA for Investigating eIF4E-m7GpppX Capped mRNA InteractionsGabriela Vega-Hernández, Jesse Duque, Brandon J C Klein, et al.
ACS Chemical Neuroscience|December 11, 2024
Structure-Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid ReceptorMengchu Li, Xinmin Gan, Kun Liu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor ApoptosisThomas J Wubben, Sraboni Chaudhury, Brennan T Watch, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2015
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.
Translational Vision Science & Technology|July 31, 2025
A Novel, Long-Acting, Small Molecule PKM2 Activator and Its Potential Broad Application Against Photoreceptor DegenerationWarren W Pan, Katherine M Weh, Sraboni Chaudhury, et al.
JCI Insight|July 27, 2018
From proteomics to discovery of first-in-class ST2 inhibitors active in vivoAbdulraouf M Ramadan, Etienne Daguindau, Jason C Rech, et al.
Pageof 9